Published in Aust N Z J Med on December 01, 1978
Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis. J Carcinog (2007) 0.91
Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma. World J Surg Oncol (2008) 0.87
Clinical applications of receptor measurements in breast cancer. Br J Cancer (1980) 0.75
Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell (1993) 3.84
Season of initial discovery of tumour as an independent variable predicting survival in breast cancer. Br J Cancer (1990) 2.55
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci U S A (1993) 2.24
Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome. Physiol Genomics (1999) 1.58
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
The acromegalic rosary. Lancet (1991) 1.43
Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) (1994) 1.40
Variation in receptor status between primary and metastatic breast cancer. Cancer (1983) 1.36
Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res (1983) 1.31
Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy. Cancer Res (1999) 1.24
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome. Diabet Med (2003) 1.12
Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus. Br Med J (Clin Res Ed) (1985) 1.10
Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer (1996) 1.09
Survival of women with node negative breast cancer in the Auckland region. N Z Med J (1996) 1.08
Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol (1998) 1.07
Reliability of steroid hormone receptor assays: an international study. Eur J Cancer Clin Oncol (1983) 1.06
Circulating corticotrophin levels in severe hypopituitarism and in the neonate. Lancet (1973) 1.05
Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status. Breast Cancer Res Treat (1985) 1.02
Association between season of first detection of breast cancer and disease progression. Breast Cancer Res Treat (1987) 1.01
Cloning and functional characterization of a family of receptors for the melanotropic peptides. Ann N Y Acad Sci (1993) 1.01
Detection of familial dysalbuminaemic hyperthyroxinaemia. Br Med J (Clin Res Ed) (1985) 1.00
New bioassay for luteinizing hormone. Nature (1973) 0.99
Abnormal insulin-receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cells. Cancer Res (1987) 0.97
Hormone binding by human mammary carcinoma. Cancer Res (1977) 0.94
Validation of the redox cytochemical assay for corticotrophin. Clin Endocrinol (Oxf) (1974) 0.93
Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid. Br J Cancer (1999) 0.91
Insulin receptor regulation in cultured human tumor cells. Cancer Res (1983) 0.90
Mapping of the ACTH, MSH, and neural (MC3 and MC4) melanocortin receptors in the mouse and human. Mamm Genome (1994) 0.89
Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging. Intern Med J (2003) 0.89
Milk alkali syndrome following over-the-counter antacid self-medication. N Z Med J (1986) 0.88
Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. Auckland Breast Cancer Study Group. N Z Med J (1992) 0.86
Season of tumour detection influences factors predicting survival of patients with breast cancer. Breast Cancer Res Treat (1990) 0.84
Melanocortin receptor binding determinants in the agouti protein. Biochemistry (1998) 0.84
Mouse melanocortin-4 receptor gene 5'-flanking region imparts cell specific expression in vitro. Mol Cell Endocrinol (2001) 0.84
Miliary tuberculosis with hypercalcaemia and raised vitamin D concentrations. Thorax (1987) 0.83
Evidence for independent regulation of human erythrocyte and adipocyte insulin receptors. Clin Endocrinol (Oxf) (1982) 0.81
Correlation between hormone binding and growth response of rat mammary tumor. Cancer Res (1976) 0.81
Applications of the redox bioassay for luteinizing hormone. Clin Endocrinol (Oxf) (1974) 0.81
Ectopic secretion of ACTH and met-enkephalin from a thymic carcinoid. J Endocrinol Invest (1982) 0.81
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate). Aust N Z J Med (1984) 0.81
Acute retinal pigment epitheliitis associated with intravenous bisphosphonate. Br J Ophthalmol (2006) 0.80
Height-related risk factors for prostate cancer. Br J Cancer (2000) 0.80
Comparison of the redox bioassay with other assays for luteinizing hormone. J Endocrinol (1976) 0.80
Experience with a short test of pituitary-adrenal function. Aust N Z J Med (1973) 0.80
Differential expression of cocaine- and amphetamine-regulated transcript and agouti related-protein in chronically food-restricted sheep. Brain Res (2001) 0.80
Insulin binding by normal and neoplastic colon tissue. Int J Cancer (1985) 0.78
Technical aspects of the redox bioassay for luteinizing hormone. Clin Endocrinol (Oxf) (1974) 0.78
Long-term alterations in body weight do not affect the expression of melanocortin receptor-3 and -4 mRNA in the ovine hypothalamus. Neuroscience (2001) 0.78
Insulin receptors in human cancer. Br J Cancer (1981) 0.78
Regulation of insulin binding to human mammary carcinoma. Cancer Res (1982) 0.78
Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD. Br J Radiol (1987) 0.77
The effect of extradural blockage upon glucose and urea kinetics in surgical patients. Surg Gynecol Obstet (1987) 0.77
Serum IGF-I levels are similar in Samoan, Māori and European populations despite differences in body composition. Growth Horm IGF Res (2006) 0.77
Parathyroid cyst with recurrent vocal cord paresis. Aust N Z J Surg (1993) 0.77
A familial syndrome of cardiac myxomas, myxoid neurofibromata, cutaneous pigmented lesions, and endocrine abnormalities. Aust N Z J Med (1986) 0.76
Incidence and clinical features of breast cancer in the Auckland region. N Z Med J (1992) 0.76
Molecular genetics of the ACTH and melanocyte-stimulating hormone receptors. Trends Endocrinol Metab (1993) 0.76
The serum prolactin level in testicular tumours--a new tumour marker? Aust N Z J Surg (1980) 0.76
High peripheral and axial bone densities in a postmenopausal woman with untreated hypoparathyroidism. Postgrad Med J (1990) 0.76
Influence of thyroidectomy and prolactin suppression on the growth of N-nitrosomethylurea-induced rat mammary carcinomas. Cancer Res (1983) 0.76
Treatment of breast cancer in the Auckland region 1976-85. N Z Med J (1994) 0.76
Objective assessment of treatment response in hirsutism. Horm Res (1985) 0.76
Comparison of two low-dose calcium infusion schedules for localization of insulinomas by selective pancreatic arterial injection with hepatic venous sampling for insulin. Clin Endocrinol (Oxf) (2013) 0.75
Hypercalcaemia during resolution of calcinosis in juvenile dermatomyositis. Br Med J (Clin Res Ed) (1984) 0.75
Cutaneous insulin allergy responsive to oral desensitisation and aspirin. Br Med J (Clin Res Ed) (1984) 0.75
Elevated thyroid hormone levels with normal or raised thyroid-stimulating hormone: a diagnostic and therapeutic dilemma. Intern Med J (2001) 0.75
Clinical applications of receptor measurements in breast cancer. Br J Cancer (1980) 0.75
Watery diarrhoea syndrome with episodic hypercalcaemia. Aust N Z J Med (1977) 0.75
Investigation and management of symptomatic hyperprolactinaemia. Aust N Z J Obstet Gynaecol (1979) 0.75
Influence of magnesium on the secretion and action of parathyroid hormone. J Endocrinol Invest (1980) 0.75
Effects of metformin and glibenclamide on insulin receptors in fibroblasts and tumor cells in vitro. J Endocrinol Invest (1987) 0.75
Proceedings: Measurement of plasma adrenocorticotrophin levels in normal and hypopituitary subjects by redox bioassay. J Endocrinol (1973) 0.75
Clinical and biochemical evaluation of patients with hirsutism. Aust N Z J Obstet Gynaecol (1984) 0.75
Cyproterone acetate as initial treatment and maintenance therapy for hirsutism. Acta Endocrinol (Copenh) (1985) 0.75
An indoline-derived compound that markedly reduces mouse body weight. Int J Obes (Lond) (2012) 0.75
Measurement of nuclear oestrogen receptors in human breast tumours. Aust N Z J Surg (1989) 0.75
Insulin resistance with acanthosis nigricans and acral hypertrophy. N Z Med J (1984) 0.75
Proceedings: Modifications of the redox bioassay of luteinizing hormones. J Endocrinol (1974) 0.75
Suppression of plasma ACTH levels with corticosteroids in Addison's disease. Clin Endocrinol (Oxf) (1973) 0.75
Estrogen receptor status, adrenal androgens and 7 alpha-hydroxydehydroepiandrosterone in breast cancer patients. Eur J Cancer Clin Oncol (1984) 0.75
Influence of infused prolactin on hormone binding to tissue slices. Can J Physiol Pharmacol (1977) 0.75
The case for growth hormone replacement in adult hypopituitarism. N Z Med J (1996) 0.75
Bromoergocryptin treatment of acromegaly persisting following conventional therapy. Clin Endocrinol (Oxf) (1978) 0.75
Low thyroxine levels in some hyperprolactinemic patients due to dopaminergic suppression of thyrotropin. J Clin Endocrinol Metab (1984) 0.75
Loss of insulin binding and insulin receptor mRNA in a transformed human fetal fibroblast cell line. Biochem Biophys Res Commun (1990) 0.75
Neurofibromatosis associated with somatostatinoma: a report of two patients. Clin Endocrinol (Oxf) (1988) 0.75
Sources of improvement in between laboratory variation in estrogen and progestin receptor measurement using tissue samples during the Australian Quality Assurance Programme. Eur J Cancer Clin Oncol (1989) 0.75
Comparison of histochemical and biochemical assays for oestrogen receptor in breast tumour tissue. Aust N Z J Surg (1986) 0.75
Criteria for cure in acromegaly: report of a case apparently cured in which persisting tumor was found at autopsy. Neurosurgery (1984) 0.75
Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth. Clin Endocrinol (Oxf) (1976) 0.75
Steroid hormone receptors in breast tumours presenting during pregnancy or lactation. J Surg Oncol (1984) 0.75
The response to treatment with pituitary growth hormone: the New Zealand experience. N Z Med J (1989) 0.75
Identification of the major sources of error in estrogen receptor measurements for individual laboratories using both tissue and cytosol samples. Eur J Cancer Clin Oncol (1989) 0.75